By Gina Shaw
The FDA and state regulatory agencies should investigate unregulated direct access infusion businesses, according to a statement issued on Jan. 18 by the National Home Infusion Association (NHIA), ASHP, the American Society for Parenteral and Enteral Nutrition (ASPEN), and several allied organizations.
JANUARY 21, 2022